Startup profile for XpertDox: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

XpertDox funding, valuation and investors

Autonomous medical coding software converting outpatient encounter notes into coded claims inside existing EHR workflows.

Verified company research · funding, investors and latest developments

Keep track of XpertDox

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series A

$20M · November 11, 2026

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$20M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series a · Scottsdale, Arizona, United States

Investors in latest funding

Lead: Savant Growth

Other: Kennet Partners

Sources: latest funding · xpertdox.com Last verified: 2026-11-15

Overview

XpertDox was founded in 2015 by physician-scientists Sameer Ather (CEO) and Bhupesh Panwar (president and COO). It supplies XpertCoding to community health centers, urgent care groups and other outpatient providers. An original Nov 11 2026 company statement announced a $20M Series A led by Savant Growth with Kennet Partners; no valuation or closing date was given. Savant is described as a private equity investment firm in the release.

The company reports >91% touchless coding of claims, under-24-hour typical turnaround and <2% coding-related denials. It reported doubled revenue over 12 months, 126% net revenue retention and 95% customer retention; absolute sales and audit methodology were undisclosed.

A selected named customer, Lone Star Circle of Care, reports a 94% reduction in manual coding effort and 10% better charge capture; such a testimonial cannot establish causal outcomes for all buyers. First-party sources: https://www.xpertdox.com/news/xpertdox-raises-20m-for-ai-medical-coding-from-savant-growth/ ; https://www.xpertdox.com/primary-care/coding-software-for-primary-care/ .

Why XpertDox is interesting

The physician-founded company announced a $20M Series A in November 2026. It is an established outpatient revenue-cycle product, with concrete buyer economics and measurable—though largely vendor-reported—performance claims.

Product & use cases

Illustrative, source-grounded outpatient workflow: (1) clinician finishes a visit and records documentation in Epic, athenahealth, eClinicalWorks, NextGen or other integrated EHR; (2) XpertCoding ingests encounter notes; (3) its neural, ensemble, symbolic and payer-rule engine recommends diagnosis/procedure codes, detects missing documentation and produces coded claims; (4) routine claims proceed without manual coding; (5) exceptions require human review; (6) billing and clinical managers review trends and denials in dashboards. Vendor markets flexible per-CLAIM pricing but has not posted a dollar rate; implementation fees and true all-in costs require a quotation. A buyer should audit a pilot against its own payer mix and visit specialties.

  • Federally qualified health centers reducing manual medical coding across diverse outpatient visit types.
  • Urgent care and pediatric provider organizations seeking faster claim submission.
  • Revenue-cycle managers monitoring payer denials, charge capture, review exceptions and coding quality.

Key facts

  • New $20M Series A announced Nov 11 2026, led by Savant Growth with Kennet Partners funding.
  • Claims of >91% no-touch coding, <24h turnaround and <2% coding denials are issuer-reported, not independently audited.
  • Company-reported doubled revenue in last 12 months, 126% NRR and 95% retention; absolute revenue not disclosed.
  • Named vendor-selected Lone Star Circle of Care case cites 94% manual-work reduction, 10% increased charge capture.
  • Per-claim commercial model public, but numerical unit rate not published.

Funding history (newest first)

Series A

2026-11-11 $20M
  • Savant Growth (lead)
  • Kennet Partners (participant)

Source: Read source · xpertdox.com

Competitive landscape

Edge: Claims to combine domain-specific neural and symbolic AI with payer rules, coding automation, clinical-documentation improvement and analytics. Independent product comparisons and cross-specialty validation remain important.

At procurement, confirm per-claim fee, trial population and service-line support, code accuracy versus independent auditors, coding-related denials with attribution, exception rate, EHR integration and posting methods, BAA and auditability. Selected vendor case studies are evidence of reference customer reports, not controlled evidence of customer outcome causality. Public documents do not establish full inpatient DRG support.

  • Fathom direct

    Autonomous medical coding for providers; examine claim coverage and audit controls.

  • CodaMetrix direct

    Clinical coding automation with healthcare system focus; evaluate supported encounters.

  • Nym direct

    Autonomous medical coding with differing workflows and payer-specialty coverage.

  • Solventum 360 Encompass incumbent

    Established computer-assisted coding and CDI workflow alternative.

Market / IPO context

Editorial / static context — not a live quote.

FAQs about XpertDox

Practical answers founders, operators, and investors typically search for.

The company discloses a per-claim commercial model but not an actual per-claim dollar fee. Obtain a tailored quote.
It disclosed a new $20M Series A led by Savant Growth on November 11. The total cumulative financing and valuation were not provided.
The percentages in the financing release and company case studies are vendor-reported. Buyer-specific audits are necessary.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.